文献速递腹部MR

基线分期MRI的扩散峰度与扩散系数作为局部进展期直肠癌新辅助放化疗反应预测生物标志物的评估

Evaluation of diffusion kurtosis and diffusivity from baseline staging MRI as predictive biomarkers for response to neoadjuvant chemoradiation in locally advanced rectal cancer.
PubMed 文献 · Abdom Radiol (NY) · 2019-01-01

本回顾性研究纳入45例局部进展期直肠癌患者,于基线MRI行高b值序列(至1500 mm/s²)并手动分割T2加权图像,提取扩散峰度与扩散系数及体积数据。结果显示较高的扩散系数汇总值(Dsum)与更有利的肿瘤回归分级(TRG 0或1)相关,而扩散峰度及体积数据与TRG无显著关联;作者认为扩散系数有潜力作为预测新辅助放化疗反应的影像生物标志物。

要点

  • 基线MRI提取的扩散系数汇总值(Dsum)越高,患者越可能处于更有利的TRG分组(TRG 0或1)。
  • 扩散峰度(ROI及VOI的均值与中位数)及肿瘤体积数据与TRG无显著关联。
  • TRG 0/1患者5年无病生存率为90-98%,TRG 2/3患者为68-73%。

核心结论

  • 基线分期MRI衍生的扩散系数(而非扩散峰度或体积数据)与TRG相关,有潜力作为预测局部进展期直肠癌新辅助放化疗反应的影像生物标志物。

研究设计与样本

  • 回顾性研究,纳入45例连续患者(男31例/女14例,平均年龄57.4岁,范围34.2-72.9岁),于基线行高b值序列(至1500 mm/s²)MRI,随后接受新辅助放化疗及手术切除;由一名腹部放射科医生使用开源软件手动分割T2加权图像,提取扩散峰度与扩散系数及体积数据;采用四分类AJCC TRG(0-3级)作为参考标准。

诊断标准与关键数值

  • 采用四分类AJCC TRG分类(TRG 0-3)评估肿瘤回归分级。
  • 单变量比例优势回归分析显示,较高的Dsum值与处于更有利TRG分组(TRG 0或1)的更高比值比显著相关。
  • 敏感性分析中,除ROI-max D中位数(p=0.08)外,大多数Dsum值较高均与TRG 0或1的更高比值比显著相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To evaluate the role of diffusion kurtosis and diffusivity as potential imaging biomarkers to predict response to neoadjuvant chemoradiation therapy (CRT) from baseline staging magnetic resonance imaging (MRI) in locally advanced rectal cancer (LARC).

MATERIALS AND METHODS: This retrospective study included 45 consecutive patients (31 male/14 female) who underwent baseline MRI with high b-value sequences (up to 1500 mm/s2) for LARC followed by neoadjuvant chemoradiation and surgical resection. The mean age was 57.4 years (range 34.2-72.9). An abdominal radiologist using open source software manually segmented T2-weighted images. Segmentations were used to derive diffusion kurtosis and diffusivity from diffusion-weighted images as well as volumetric data. These data were analyzed with regard to tumor regression grade (TRG) using the four-tier American Joint Committee on Cancer (AJCC) classification, TRG 0-3. Proportional odds regression was used to analyze the four-level ordinal outcome. A sensitivity analysis was performed using univariable logistic regression for binary TRG groups, TRG 0/1 (> 90% response), or TRG 2/3 (< 90% response). p < 0.05 was considered significant throughout.

RESULTS: In the univariable proportional odds regression analysis, higher diffusivity summary (Dsum) values were observed to be significantly associated with higher odds of being in one or more favorable TRG group (TRG 0 or 1). In other words, on average, patients with higher Dsum values were more likely to be in a more favorable TRG group. These results are mostly consistent with the sensitivity analysis, in which higher values for most Dsum values [all but region of interest (ROI)-max D median (p = 0.08)] were observed to be significantly associated with higher odds of being TRG 0 or 1. Tumor volume of interest (VOI) and ROI volume, ROI kurtosis mean and median, and VOI kurtosis mean and median were not significantly associated with TRG.

CONCLUSION: Diffusivity derived from the baseline staging MRI, but not diffusion kurtosis or volumetric data, is associated with TRG and therefore shows promise as a potential imaging biomarker to predict the response to neoadjuvant chemotherapy in LARC.

CLINICAL RELEVANCE STATEMENT: Diffusivity shows promise as a potential imaging biomarker to predict AJCC TRG following neoadjuvant CRT, which has implications for risk stratification. Patients with TRG 0/1 have 5-year disease-free survival (DFS) of 90-98%, as opposed to those who are TRG 2/3 with 5-year DFS of 68-73%.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Bates DDB, Mazaheri Y, Lobaugh S, et al. Evaluation of diffusion kurtosis and diffusivity from baseline staging MRI as predictive biomarkers for response to neoadjuvant chemoradiation in locally advanced rectal cancer. Abdom Radiol (NY). 2019. PMID: 31154482. doi:10.1007/s00261-019-02073-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。